FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

BPC-157

Body Protection Compound 15-mer

≥ 99.0%CAS 137525-51-0Repair Peptides

Overview

BPC-157 is a pentadecapeptide derived from a protective protein found in gastric juice, widely used in tissue-repair, gastrointestinal mucosa, and tendon-ligament research. PeptideXpo supplies BPC-157 acetate as a lyophilized powder at ≥99% HPLC purity, with sequence verification on request.

Specifications

CAS
137525-51-0
Molecular Formula
C62H98N16O22
Molecular Weight
1419.55 g/mol
Sequence
GEPPPGKPADDAGLV
Appearance
White lyophilized powder
Purity (HPLC)
≥ 99.0%
Common vial sizes
2 mg, 5 mg, 10 mg
MOQ
On request
Lead time
7–14 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification

Regulatory note

Currently under FDA PCAC review (July 2026) for inclusion on the 503A bulks list. Supplied for research and commercial use in compliance with the buyer's local regulations.

Frequently asked questions

What is the sequence of BPC-157?

BPC-157 is a 15-amino-acid peptide with sequence GEPPPGKPADDAGLV.

Is BPC-157 approved by the FDA?

BPC-157 is currently under FDA Pharmacy Compounding Advisory Committee (PCAC) review for the 503A bulks list (July 2026). Until then, it is sold for research-use-only or commercial use in jurisdictions where permitted.

What vial sizes are available?

Standard 2 mg, 5 mg, and 10 mg lyophilized vials. Custom fills and blends (e.g., BPC-157 + TB-500 'Wolverine Blend') available via OEM service.